Inventor

SAPIENZA JOHN

US25 patents

⚠️ This page may combine multiple inventors who share the name “SAPIENZA JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SAPIENZA JOHN

SIGNAL PHARM LLC

Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

Methods of using indazole derivatives as JNK inhibitors

Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith

Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith

Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith

Methods of synthesis and purification of heteroaryl compounds

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors

CELGENE CORP

Antiproliferative compounds, and their pharmaceutical compositions and uses

Antiproliferative compounds, and their pharmaceutical compositions and uses

Antiproliferative compounds, and their pharmaceutical compositions and uses

Antiproliferative compounds, and their pharmaceutical compositions and uses

PERRIN-NINKOVIC SOPHIE

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway

SIGNAL PHARM INC

Indazole derivatives as JNK inhibitors and compositions and methods related thereto

HARRIS ROY L

Methods of synthesis and purification of heteroaryl compounds

ALBERS RONALD J

Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

BAHMANYAR SOGOLE

Aminotriazolopyridines, compositions thereof, and methods of treatment therewith